Search Results
Nov 14, 2025, 06:30 ET Range Extended Electric Vehicle Market worth 3.2 million units by 2030 | MarketsandMarkets™
MarketsandMarkets™. The REEV market is growing due to high emission targets set by the governing bodies of European countries and the Chinese government. Moreover, EU7 has strict emission regulations, which have boosted the sales of REEV in the region and will continue to be the primary reason for the growth. Moreover,
More news about: MarketsandMarkets
Nov 14, 2025, 05:45 ET World Digital Foundation Releases Independent Report Showing Portugal's Golden Visa Has Generated Over €54 Billion in Economic Impact
decade later, its evolution shows that the programme's real success lies in the ecosystem it has built: a globally trusted residency framework within the EU and Schengen zone, a magnet for internationally mobile professionals, and a generator of investment into productive sectors. "The
More news about: World Digital Foundation
Nov 14, 2025, 05:45 ET World Digital Foundation Releases Independent Report Showing Portugal's Golden Visa Has Generated Over €54 Billion in Economic Impact
decade later, its evolution shows that the programme's real success lies in the ecosystem it has built: a globally trusted residency framework within the EU and Schengen zone, a magnet for internationally mobile professionals, and a generator of investment into productive sectors. "The
More news about: World Digital Foundation
Nov 14, 2025, 05:37 ET 아드녹 가스, 사상 최고 3분기 실적 달성...역동적 시장 속 탄탄한 성장과 회복력 입증
content:https://www.prnewswire.com/kr/news-releases/uC544uB4DCuB179u002DuAC00uC2A4u002Cu002DuC0ACuC0C1u002DuCD5CuACE0u002Du0033uBD84uAE30u002DuC2E4uC801u002DuB2ECuC131u002Eu002Eu002EuC5EDuB3D9-302615524.html
More news about: ADNOC Gas
Nov 14, 2025, 03:36 ET Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine
eptinezumab was generally similar to placebo, previous trials, and to the current labelled safety information in the United States prescribing information and EU Summary of Product Characteristics, with the most common treatment-emergent adverse events being COVID-19 and nasopharyngitis. Lundbeck
More news about: H. Lundbeck A/S
Nov 14, 2025, 03:00 ET BIRKENSTOCK WINS DUTCH LANDMARK COPYRIGHT CASE: UTRECHT COURT BANS SALE OF SANDAL COPIES, MARKING KEY STEP TOWARD EU-WIDE COPYRIGHT RECOGNITION OF THE BRAND'S ICONIC SANDALS
Mio and konektra case which is expected for December 4, 2025 and which will address key issues relating to copyright protection for product design at EU level.
More news about: BIRKENSTOCK Group
Nov 14, 2025, 01:31 ET Thomas Bach visite Guangzhou et fait l'éloge de One Heung Kong : vraiment magnifique !
retentissant, tant pour les athlètes que pour les organisateurs. À la résidence des champions One Heung Kong, M. Bach a en outre eu des échanges chaleureux et amicaux avec plusieurs représentants de champions sportifs, notamment Tang Jiuhong, championne du monde de badminton, Wu Dajing,
More news about: Heungkong Group
Nov 13, 2025, 17:31 ET ObesityWeek 2025: Breakthrough Results Reshaping the Obesity Market Landscape | DelveInsight
anti-obesity market is projected to grow from USD 12 billion in 2024 to approximately USD 86 billion by 2034 across the leading markets (the US, EU4, the UK, and Japan), representing a 617% increase, as per DelveInsight. These market projections reflect multiple expanding vectors: the newly
More news about: DelveInsight Business Research, LLP
Nov 13, 2025, 16:11 ET Blue Moon Metals Announces Voting Results from Annual and Special Meeting and Welcomes new Norwegian-based Board Members
are well located with existing local infrastructure including roads, power and historical infrastructure. Zinc and copper are currently on the USGS and EU list of metals critical to the global economy and national security. Major shareholders include Oaktree, Hartree, Wheaton Precious Metals, Baker Steel
More news about: Blue Moon Metals
Nov 13, 2025, 12:49 ET Bone Health Supplements Market to Reach $23.1 billion, Globally, by 2034 at 5.3% CAGR: Allied Market Research
and France have high consumption rates of supplements, with physicians often integrating them into standard osteoporosis prevention protocols. Strict EU quality regulations also ensure high product standards, enhancing consumer trust and driving market growth. Asia-Pacific is the
More news about: Allied Market Research
Nov 13, 2025, 12:30 ET Axelar, Midas & Lista DAO Launch mXRP on BNB Chain
Fordefi. Redemptions are initiated by users non-custodially and executed through third-party audited smart contracts. The product is issued under an EU-approved prospectus. "Incentives move the world, and yield is the most powerful incentive to move the world onchain,"
More news about: Axelar
Nov 13, 2025, 09:00 ET MoonPay Launches Enterprise Stablecoin Services, Integrates with M0, Appoints Former Paxos Exec to Lead
economy, MoonPay is a key driver behind mainstream crypto adoption. It is licensed in the U.S. and regulated in the UK, EU, Canada and Australia—and has been certified for its enterprise-grade security. MoonPay is changing payments.
More news about: MoonPay
Nov 13, 2025, 09:00 ET IM Cannabis Reports Third Quarter 2025 Financial Results
in Germany; the Company's growth in 2025; the market growth for medicinal cannabis in Germany; the stated benefits of the Company's EU-GMP processing facility and an EU-GDP logistics center; the Company's ability to find new business activities to broaden its growth avenues and support long-term value
More news about: IM Cannabis Corp.
Nov 13, 2025, 09:00 ET IM Cannabis Reports Third Quarter 2025 Financial Results
in Germany; the Company's growth in 2025; the market growth for medicinal cannabis in Germany; the stated benefits of the Company's EU-GMP processing facility and an EU-GDP logistics center; the Company's ability to find new business activities to broaden its growth avenues and support long-term value
More news about: IM Cannabis Corp.
Nov 13, 2025, 08:30 ET Why Transmission Electron Microscopy Is Key to Cell Line Characterization, Upcoming Webinar Hosted by Xtalks
Consultant; and Gail Collinson, BSc (Hons), Senior Scientist, Cell Biology, for the live webinar on Monday, December 8, 2025, at 10am EST (4pm CET/EU-Central). For more information, or to register for this event, visit
More news about: Xtalks
Nov 13, 2025, 08:30 ET Riding the data wave: How pharma can navigate disruptions in open claims, Upcoming Webinar Hosted by Xtalks
company, Ram Bendre, Principal; and Stephen Bielecki, Strategic Accounts Partner, for the live webinar on Monday, December 8, 2025, at 12pm EST (6pm CET/EU-Central). For more information, or to register for this event, visit
More news about: Xtalks
Nov 13, 2025, 08:13 ET iOS users benefit from browser alternatives - Opera reports up to 5x growth in key markets
Europe has nearly tripled over the past two years, a testament to the importance of the Digital Markets Act (DMA) to promote browser competition in the EU. Individual key markets have grown even faster, such as France, where the active user base increased 5 times over the same period.
More news about: Opera Limited
Nov 13, 2025, 08:03 ET NextPlat Reports Third Quarter 2025 Results
limited inventory levels, sales activity and sell-through remains high. In September, NextPlat also launched its Florida Sunshine products in the UK and EU and began processing orders via its Amazon and Shopify e-commerce storefronts. The Company is also preparing the launch of an Artificial Intelligence
More news about: NextPlat Corp.
Nov 13, 2025, 07:00 ET Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
the company's transition from a clinical-stage biotech to a commercial-ready organization in gene therapies. There, he developed the company's U.S., EU, and Japan commercialization strategies and go-to-market models including infrastructure and secured pre-launch payer agreements – all designed to accelerate
More news about: Neurvati Neurosciences
Nov 13, 2025, 07:00 ET DJI, 신제품 'DJI Neo 2' 출시…더 안전하고 창의적인 비행으로 돌아온 '팔로우 미' 카메라 드론
multimedia:https://www.prnewswire.com/kr/news-releases/u0064u006Au0069u002Cu002DuC2E0uC81CuD488u002Du0027u0064u006Au0069u002Du006Eu0065u006Fu002Du0032u0027u002DuCD9CuC2DCu2026uB354u002DuC548uC804-302609630.html
More news about: DJI
Nov 13, 2025, 06:50 ET Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
weeks (E2W) dosing regimen. The 1 mg/kg E2W regimen is unaffected and remains approved as a dosing regimen of Elfabrio in the EU. Third Quarter 2025 Financial Highlights
More news about: Protalix BioTherapeutics, Inc.
Nov 13, 2025, 03:00 ET La Niña's Chill Underscores Volatility Outlook for European Energy, Notes Mitrade CFD Broker
is expected to import up to 160 additional LNG cargoes this winter due to lower storage levels and reduced pipeline flows from Russia and Algeria. The EU Council has agreed its position on a draft regulation introducing a stepwise, legally binding ban on Russian gas imports by 1 January 2028.
More news about: Mitrade EU
Nov 13, 2025, 03:00 ET Die Kälte von La Niña unterstreicht die volatilen Aussichten für den europäischen Energiemarkt, bemerkt der CFD-Broker Mitrade
zusätzliche LNG-Ladungen importieren müssen, da die Lagerbestände gesunken sind und die Pipelinetransporte aus Russland und Algerien zurückgegangen sind. Der EU-Rat hat sich auf seinen Standpunkt zu einem Verordnungsentwurf geeinigt, der ein schrittweises, rechtsverbindliches Verbot russischer Gasimporte bis
More news about: Mitrade EU
Nov 13, 2025, 02:23 ET Interim Report for the period July - September 2025: BioArctic
brings additional treatment options for physicians and patients and has the potential to help us help many more patients. In the EU, we celebrated Eisai's first launches in Austria and Germany, and after the quarter ended, also recorded the first patient on treatment in Finland at
More news about: BioArctic
Nov 13, 2025, 02:19 ET Interim Report for the period July - September 2025: BioArctic
brings additional treatment options for physicians and patients and has the potential to help us help many more patients. In the EU, we celebrated Eisai's first launches in Austria and Germany, and after the quarter ended, also recorded the first patient on treatment in Finland at
More news about: BioArctic